Insmed Incorporated
Richmond, VA
Ticker: Nasdaq: INSM
Insmed is focused on the development of drugs to treat metabolic and endocrine-related diseases and disorders associated with insulin resistance. The company went public in October 2000.
Ticker: Nasdaq: INSM
Insmed is focused on the development of drugs to treat metabolic and endocrine-related diseases and disorders associated with insulin resistance. The company went public in October 2000.